MDR vs. MDD: 13 Key Changes
All Those involved in medical device field must be thorough
with MDD (Medical device directive) and now familiar and knowledgeable with new
regulation by EU MDR (Medical device regulations) Like MDR was made to replace
MDD and then it was applicable to EU and UK, however situation changed for UK
after BREXIT. We will restrict our blog to MDD Vs. MDR and what major changes
are there which manufacturer or distributor must take care if they need to
continue business in EU countries. (With Brexit even business with UK will also
be possible if MDR is followed if certain aspects are taken care for
administrative purpose)
Timeline:
There are no devices grandfathered in MDR. So, all the
manufacturer who were under grand fathered status under MDD need to transit to
MDR now itself.
Even though, as suggested above you can continue to market
as late as 26th May 2025, there are lot of restrictions.
2. Device
must remain in compliance to the state-of-the-art requirement, including EU
issued common specification and recognised standards.
3. PMS
(Post market surveillance) requirement must be implemented along with PMCF
(Post market clinical follow up) or justification is required why no PMCF.
4. Registration
requirement for all economic operators need completion. Manufacturer must
ensure that quality agreement is in place for Authorised representative, importer,
and distributor.
In above situation it is advisable to hire MDD to MDR consultants for gap assessment and transition preparation. These consultants
can take up CER reviews as well as training also. Certain aspects of future job
can be accomplished through MDR consultants also as interpretation of various
clauses of MDR need an expert and experienced eye.
1. MDD
vs. MDR: Let us understand some verbatim changes so significance can be understood,
and detailing can be worked out.
2. MDR
is almost four times larger than MDD.
3. The
word “Safety” appears 240 times against only forty times in MDD. This signifies
stress and approach and required technical documentation changes.
4. Stress
on conducting global impact assessment and to remain in compliance thereafter.
5. New
safety and performance requirements which identifies new condition need to be
addressed. (Like, CE mark under MDD and product re-certification)
6. UDI
implementation.
7. MDD
scope did not encompass medical purpose of medical device and AIMDD, both are
part of MDR.
8. Definition
of medical device is broadened to include non-medical and cosmetic devices
which were not previously in scope of regulation. (Ex, contact lens,
liposuction equipment)
9. More
in depth clinical data and evaluation.
10. Reporting
of all incidents, serious incidents including death now needs reporting in EU
portal as centralised data for better access for patient. Non serious incident
reporting time reduced from 30 days to 15 days.
11. Companies
undergoing transitions shall have to pay more attention on core processes of
QA, risk management and post market expectations. These all must be aligned to
new requirement.
12. Reclassification
of many medical devices will be required to higher risk class. New
classification for reusable surgical devices will require notified body
oversight. (Notified body come in picture)
13. IVD
are classified now into four risk classes. 90 % of them will now come under
purview of notified bodies as against earlier only 10 %.
MDR is effective now but certain medical devices compliant
with MDD/AIMDD can continue till 26th May 2024 provided there is no
significant change in device and intended purpose.
Looking at above 13 changes and maintain the timeline and continuity
of business, MDD to MDR consultant or MDR consultant support is advisable.
Our “ONE-STOP COMPLETE SOLUTION” include –
·
Gap Assessment
·
Technical File Preparation
·
QMS Documentation
·
Expert Review & Recommendations
·
European Authorized Representative (EC REP)
·
EUDAMED
·
Mock Audits & Trainings
·
PRRC Services
·
Clinical Evaluation Plan & Report
·
Software Validation
IZiel team of specialists and quality professionals look
forward to support more medical device companies to file their devices under
the MDR 2017/745.
Comments
Post a Comment